<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Pathogenesis of fibromyalgia</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Pathogenesis of fibromyalgia</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Pathogenesis of fibromyalgia</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Don L Goldenberg, MD</a></dd><dt><span> </span>Section Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Peter H Schur, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Daniel J Wallace, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Siobhan M Case, MD, MHS</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Jun 12, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>The characteristic feature of fibromyalgia (FM) is chronic widespread pain in the absence of peripheral musculoskeletal inflammation or structural damage. FM may complicate many rheumatic diseases or occur independently. FM is only one of many causes of widespread pain. (See  <a class="medical medical_review" href="/z/d/html/118590.html" rel="external">"Overview of chronic widespread (centralized) pain in the rheumatic diseases"</a>.)</p><p>There is no evidence that a single event "causes" FM. Rather, many physical and/or emotional stressors may trigger or aggravate symptoms. These have included certain infections, such as a viral illness or Lyme disease, as well as emotional or physical trauma [<a href="#rid1">1,2</a>]. FM is often best viewed as a syndrome rather than a disease.</p><p>The pathogenesis of FM is presented here. A detailed description of the clinical manifestations of FM and an approach to the diagnosis and differential diagnosis of FM in adults and children are presented separately. (See  <a class="medical medical_review" href="/z/d/html/5624.html" rel="external">"Clinical manifestations and diagnosis of fibromyalgia in adults"</a> and  <a class="medical medical_review" href="/z/d/html/6426.html" rel="external">"Fibromyalgia in children and adolescents: Clinical manifestations and diagnosis"</a> and  <a class="medical medical_review" href="/z/d/html/5625.html" rel="external">"Differential diagnosis of fibromyalgia"</a>.)</p><p class="headingAnchor" id="H631211997"><span class="h1">TERMINOLOGY AND PAIN CLASSIFICATION</span><span class="headingEndMark"> — </span>Fibromyalgia (FM) is considered to be a disorder of pain regulation, often classified under the term central sensitization [<a href="#rid1">1-3</a>] (see <a class="local">'Central nervous system altered pain processing'</a> below). Central sensitization has been defined as an amplification of neural signaling within the central nervous system (CNS) resulting in pain hypersensitivity [<a href="#rid3">3</a>]. Among patients with FM, central sensitization may be accompanied by peripheral pain mechanisms, including neuropathic pain, such as small fiber neuropathy (SFN) [<a href="#rid4">4</a>], and nociceptive pain, such as an inflamed joint. (See <a class="local">'Peripheral pain mechanisms'</a> below.)</p><p>During much of the 20<sup>th</sup> century, FM was thought to be a muscle disease or related to soft-tissue inflammation, hence the term fibrositis. However, controlled comparisons found no evidence for significant pathologic or biochemical muscle abnormalities [<a href="#rid1">1,2,5-7</a>]. As an example, measures of muscle function, including force generation and lactate production during exercise, and muscle pain following exertion are remarkably similar in women with FM and sedentary controls [<a href="#rid6">6,7</a>]. Soft-tissue tender points, initially part of the FM diagnostic criteria, represent CNS pain dysregulation rather than localized pathology [<a href="#rid1">1-3</a>].</p><p>FM shares several clinical and pathophysiologic features with other common pain disorders that are considered to be more central rather than peripheral pain conditions, such as migraine, tension headaches, temporomandibular joint disorder, vulvodynia, irritable bladder and irritable bowel syndrome. Clinical characteristics of each of these conditions include widespread pain, fatigue, and sleep and mood disturbances. These conditions also share common genetic and CNS pain processing mechanisms with FM. More limited studies have suggested there might also be a role for peripheral neuropathic mechanisms or focal tissue changes in some patients. (See <a class="local">'Peripheral pain mechanisms'</a> below.)</p><p class="headingAnchor" id="H3"><span class="h1">GENETIC PREDISPOSITION AND CANDIDATE GENES</span><span class="headingEndMark"> — </span>A number of observational and biologic studies suggest that chronic widespread pain and fibromyalgia (FM) have, in part, a genetic basis [<a href="#rid8">8</a>].</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Familial studies</strong> – First-degree relatives of patients with FM are 8.5 times more likely to have FM than relatives of patients with rheumatoid arthritis [<a href="#rid9">9</a>]. Familial aggregation of lowered thresholds for pressure-induced pain has been documented in first-degree relatives of patients. Such reports suggest a shared hereditary factor that may account for the overlap of chronic pain and mood disorders in families. However, no clear association between chronic widespread pain and any single candidate gene has yet been conclusively documented [<a href="#rid10">10-12</a>].</p><p></p><p class="bulletIndent1">In a study of FM in 26,749 individuals undergoing elective surgery, younger patients with an FM phenotype had a stronger genetic component than older individuals [<a href="#rid13">13</a>]. Overall, the FM phenotype had an estimated heritability of 14 percent. FM patients were found to have a relatively unique family genetic risk profile that differed markedly from that of classic autoimmune diseases or major depression but overlapped with that for irritable bowel and chronic fatigue syndromes [<a href="#rid14">14</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Genome-wide association studies</strong> – Candidate gene studies in FM have demonstrated significant differences in allele frequencies between FM cases and controls [<a href="#rid11">11</a>]. A genome-wide linkage study found an estimated sibling recurrence risk ratio for FM of 13.6, based upon a reported FM population prevalence of 2 percent [<a href="#rid12">12</a>].</p><p></p><p class="bulletIndent1">A subsequent genome-wide profiling found that, compared with controls, patients with FM had differences in expression of 421 genes, many of which were important in pain processing [<a href="#rid15">15</a>]. Another genome-wide association study of nearly 7000 patients with chronic widespread pain found an association with the <em>RNF123</em> locus and possible association with the <em>ATP2C1</em> locus, both involved in calcium regulation [<a href="#rid16">16</a>]. This study could not confirm the association with catechol-O-methyltransferase (<em>COMT</em>) in chronic widespread pain.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Epigenetic studies</strong> – Epigenetics, which involves the study of hereditary changes not attributable to alterations in deoxyribonucleic acid (DNA) sequence, may provide new approaches to gene-environment interactions in conditions like FM. For example, DNA methylation and histone modification alter gene expression without changes in DNA. DNA methylation in patients with FM differed from healthy controls, including in genes involved in DNA repair and membrane transport [<a href="#rid17">17</a>]. The epigenetics of brain-derived neurotrophic factor (BDNF) was studied in patients with FM and comorbid myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) [<a href="#rid18">18</a>]. The serum BDNF were elevated, and lower BDNF methylation predicted higher BDNF levels and correlated with patients’ symptoms and widespread pain in the FM/ME/CFS subjects.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Serotonin and opioid pathways</strong> – The ability of some antidepressant drugs to improve symptoms suggested that genes involved in serotonin and/or catecholamine metabolic or signaling pathways might be candidates for conferring susceptibility. Pain-related genes that have been potentially associated with FM include those for <em>COMT</em>, mu-opioid receptors, voltage-gated sodium channels, guanosine triphosphate (GTP) cyclohydrolase 1, and gamma-aminobutyric acid (GABA)ergic pathways [<a href="#rid8">8,10</a>].</p><p></p><p class="bulletIndent1">Specific genes involved in the serotonin and opioid pathways have been evaluated in FM, although it is difficult to distinguish their impact on pain, fatigue, mood, or to control for patient lifestyle variables [<a href="#rid19">19</a>].</p><p></p><p class="bulletIndent1">FM studies suggest that there are opposing genetic interactions between opioid and serotonergic pathways [<a href="#rid20">20</a>]. Polymorphisms of the mu-opioid receptor gene were found to influence brain pain processing in patients with FM [<a href="#rid21">21</a>].</p><p></p><p class="headingAnchor" id="H5"><span class="h1">CENTRAL NERVOUS SYSTEM ALTERED PAIN PROCESSING</span><span class="headingEndMark"> — </span>Even prior to the advances in brain imaging studies in fibromyalgia (FM), multiple lines of evidence had demonstrated that FM is a disorder of pain processing, including the following:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Temporal summation of pain</strong> – Patients with FM experience greater-than-normal increases in the perceived intensity of pain when rapidly repetitive short noxious stimuli are administered, which is termed temporal summation of pain [<a href="#rid5">5,22</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Decreased endogenous pain inhibition</strong> – Endogenous analgesic systems appear to be deficient in FM [<a href="#rid23">23</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Pain receptors and pain-related neuropeptides</strong> – Changes are seen in opioid receptors, including upregulation in the periphery and a reduction in the brain [<a href="#rid24">24,25</a>], as well as an increased brain and plasma brain-derived neurotrophic factor (BDNF) [<a href="#rid26">26</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Central hypersensitivity</strong> – The increased pain sensitivity in FM is part of a generalized hypersensitivity to sensory stimuli, including to visual, auditory, and olfactory stimuli. Patients with FM, compared with healthy controls, have exhibited increased brain responses to both pain onset and pain offset [<a href="#rid27">27</a>]. Quantitative sensory testing demonstrated hypersensitivity to sound, as well as to heat and mechanical pain, in patients with FM compared with healthy controls [<a href="#rid28">28</a>].</p><p></p><p class="headingAnchor" id="H206922578"><span class="h1">PATHOPHYSIOLOGIC STUDIES IN FIBROMYALGIA</span></p><p class="headingAnchor" id="H1360475775"><span class="h2">Heightened pain response to experimental pain stimulus</span><span class="headingEndMark"> — </span>Functional magnetic resonance imaging (fMRI) demonstrated that patients with fibromyalgia (FM) had greater neuronal activity in pain-processing brain regions compared with controls, following the same pressure stimuli [<a href="#rid29">29</a>]. Differences in activation of pain-sensitive areas of the brain have also been noted with fMRI [<a href="#rid30">30</a>].</p><p>Patients with FM exhibited less robust activations during both anticipation of pain and anticipation of relief within regions commonly thought to be involved in sensory, affective, cognitive, and pain-modulatory processes [<a href="#rid31">31</a>]. Reduced reward/punishment signaling in FM may be related to the augmented central processing of pain and reduced efficacy of opioid treatments in these patients.</p><p>Patients with FM showed a lack of pain reduction impact from a positive emotional context [<a href="#rid32">32</a>]. Compared with controls, there was less activation in the secondary somatosensory cortex, insula, orbitofrontal cortex, and anterior cingulate cortex during positive picture pain trials.</p><p>fMRI demonstrated that, compared with controls, patients with FM had greater neuronal activity during catastrophizing, particularly in regions of the posterior cingulate cortex [<a href="#rid33">33</a>]. However, an arterial spin labelling study found no significant differences in resting state blood flow in pain processing areas between patients with FM and healthy controls [<a href="#rid34">34</a>].</p><p class="headingAnchor" id="H2851970850"><span class="h2">Changes in brain morphology</span><span class="headingEndMark"> — </span>Morphometric analysis by MRI in patients with FM shows, compared with healthy controls, a significant reduction in total gray matter volume and a threefold increase in age-associated loss of gray matter, suggesting premature aging of the brain [<a href="#rid35">35</a>]. The degree of loss was greater in patients with a longer duration of disease. Such gray matter loss, which is also reported in other chronic pain and stress-related disorders, was most prominent in regions related to stress and pain processing but was also seen in areas related to cognitive function.</p><p>Structural changes and functional connectivity of the brain during application of intermittent pressure-pain stimuli were compared between 26 patients with FM and 13 age- and sex-matched healthy controls [<a href="#rid36">36</a>]. The rostral anterior cingulate cortex in the patients with FM exhibited decreased cortical thickness, brain volume, and regional functional connectivity compared with the controls. The structural changes correlated with duration of symptoms.</p><p>Diffusion-weighted imaging has demonstrated white-matter changes in FM that may be associated with alterations in pain intensity [<a href="#rid37">37</a>]. The FM group demonstrated lower fractional anisotropy in the left body of the corpus callosum. These values were negatively associated with sensory pain, suggesting disruption of white-matter microstructure and an association with clinical pain intensity.</p><p>A systematic review of imaging studies in FM found moderate evidence that central sensitization is correlated with a gray-matter volume decrease in specific brain regions (mainly anterior cingulate cortex and prefrontal cortex) [<a href="#rid38">38</a>]. Multimodal brain imaging demonstrated that the reduced gray-matter volumes in FM patients correlated with decreased tissue water content rather than gamma-aminobutyric acid (GABA) receptor concentration, suggesting neuronal plasticity [<a href="#rid39">39</a>].</p><p class="headingAnchor" id="H2725702386"><span class="h2">Altered neurotransmitter function</span><span class="headingEndMark"> — </span>Using proton MR spectroscopy, patients with FM had significantly higher levels of glutamine within the right posterior insula compared with controls [<a href="#rid40">40</a>]. Elevated insular glutamate in FM is associated with experimental pain. Within the right posterior insula, higher levels of glutamate were associated with lower pressure-pain thresholds.</p><p>Patients with FM were evaluated for cortical excitability and intracortical modulation using transcranial magnetic stimulation of the motor cortex [<a href="#rid41">41</a>]. The patients with FM, compared with controls, had deficits in intracortical modulation of GABAergic and glutamatergic mechanisms. Using MR spectroscopy, patients with FM showed higher levels of glutamate and a higher glutamine-glutamate/creatine ratio in the right amygdala compared with controls [<a href="#rid42">42</a>]. In the patients with FM with more pain, fatigue, and depressive symptoms, inositol (Ins) levels were found to be significantly higher in the right amygdala and right thalamus.</p><p>Using proton MR spectroscopy, GABA levels in the right anterior insula were significantly lower in patients with FM compared with healthy controls [<a href="#rid43">43</a>]. No significant differences between groups were detected in the posterior insula or occipital cortex. Within the right posterior insula, higher levels of GABA were positively correlated with pressure-pain thresholds in the patients with FM.</p><p class="headingAnchor" id="H3630112800"><span class="h2">Changes in resting-state functional connectivity</span><span class="headingEndMark"> — </span>Abnormal resting-state functional connectivity of the periaqueductal gray was found in FM subjects compared with controls [<a href="#rid44">44</a>]. The authors suggested that the changes result in impaired descending pain inhibition. Altered functional connectivity with the default mode network, a region active when the brain is at rest, and the insula, a key pain-processing region, was noted in FM subjects compared with controls [<a href="#rid45">45</a>]. Altered spinal cord neuronal activity between the ventral and dorsal spinal cord was found in FM but not in controls [<a href="#rid46">46</a>]. Resting-state fMRI demonstrated altered hub structure, regions that effectively transmit neural information, in FM compared with controls [<a href="#rid47">47</a>]. Altered hub topology within the insula was associated with clinical pain intensity. The neural organization of intrinsic functional brain hubs or communities in patients with FM differed from that of controls without FM, demonstrating decreased neural stability.</p><p>Specific pain-related multisensory patterns classified patients with FM versus controls with 92 percent sensitivity and 94 percent specificity [<a href="#rid2">2</a>]. The neuroimaging brain response to pain-related fear was explored as a brain signature of FM and found to be a predictor of FM as well as its treatment response [<a href="#rid48">48</a>]. Many of the structural and functional changes noted in FM have also been demonstrated in overlapping disorders, including chronic fatigue syndrome (CFS) and irritable bowel syndrome (IBS) [<a href="#rid49">49</a>].</p><p class="headingAnchor" id="H6"><span class="h1">SLEEP/MOOD/COGNITIVE ABNORMALITIES</span><span class="headingEndMark"> — </span>Underlying central nervous system (CNS) dysfunction is suggested by the sleep, mood, and cognitive disturbances noted in the majority of patients with fibromyalgia (FM) [<a href="#rid1">1,2,50</a>]. Phasic alpha sleep activity is most characteristic of FM [<a href="#rid51">51</a>]. Some data suggest that disordered sleep patterns precede the development of pain and that abnormal sleep and pain predict depressive symptoms [<a href="#rid50">50</a>]. Some findings suggest a generalized hyperarousal state in FM. As an example, women with FM have similar nocturnal sleep disturbance to women with rheumatoid arthritis, but patients with FM report greater self-rated daytime sleepiness and fatigue [<a href="#rid52">52</a>].</p><p>A longitudinal study of 12,350 women in Norway who did not have musculoskeletal pain or physical impairments at baseline found incident FM in 327 women at follow-up [<a href="#rid53">53</a>]. There was a dose-dependent association between sleep problems and risk of FM, with an adjusted relative risk (RR) of FM of 3.43 (95% CI 2.26-5.19) among women who reported having sleep problems often or always, compared with women who never experienced sleep problems.</p><p>In a prospective, population-based study, 19 percent of more than 4000 older adults (≥50 years of age) reported new widespread pain at follow-up. Nonrestorative sleep was the strongest independent predictor of new-onset widespread pain [<a href="#rid54">54</a>].</p><p>Compared with patients with osteoarthritis and healthy controls, sleep quality was lowest and there was greater anxiety and depression in patients with FM [<a href="#rid55">55</a>]. However, there were no significant differences in polysomnographic measures of total sleep time, sleep latency, and total wake-after-sleep onset in the three groups. Furthermore, levels of alpha-delta sleep were statistically similar in FM and osteoarthritis. The quality of sleep was a strong mediator of attention, cognitive tests, and pain severity in FM [<a href="#rid56">56</a>].</p><p class="headingAnchor" id="H71474502"><span class="h1">STRESS/AUTONOMIC NERVOUS SYSTEM DYSFUNCTION</span><span class="headingEndMark"> — </span>The association of pain with sleep, mood, and cognitive abnormalities has been linked to stress reactivity and autonomic nervous system (ANS) dysfunction in fibromyalgia (FM). Sleep disturbances increase pain, which increases sympathetic cardiovascular reactivity [<a href="#rid57">57</a>].</p><p class="headingAnchor" id="H7"><span class="h2">Hypothalamic-pituitary-adrenal axis and stress</span><span class="headingEndMark"> — </span>Hyperactivity of the stress response, demonstrated by abnormalities of the hypothalamic-pituitary-adrenal (HPA) axis, has been found using different baseline and provocative testing, although the precise nature of these changes has not been elucidated [<a href="#rid58">58</a>]. There was a correlation between cerebrospinal levels of corticotropin-releasing factor, sensory pain, and variation in autonomic function in patients with FM [<a href="#rid59">59</a>]. There was also a strong correlation between cortisol levels and pain upon awakening and one hour after waking in patients with FM compared with controls [<a href="#rid60">60</a>]. Subjects with chronic widespread pain had higher serum cortisol levels than controls, and there was a significant correlation of HPA axis dysfunction with developing chronic widespread pain [<a href="#rid61">61</a>]. Serum cortisol levels, considered a proxy for stress, varied with the severity of neuropsychological deficits in patients with FM [<a href="#rid62">62</a>], and a systematic review failed to find a significant alteration of blood levels of cortisol, adrenocorticotropic hormone (ACTH), corticotrophin-releasing hormone (CRH) and epinephrine in FM [<a href="#rid63">63</a>].</p><p>Evidence for ANS dysfunction includes:</p><p class="bulletIndent1"><span class="glyph">●</span>In a study involving 58 women, including patients with FM and healthy age-matched controls, urinary catecholamines and heart rate were assessed for a 24-hour period in a controlled hospital setting (including relaxation, a test with prolonged mental stress, and sleep) and during daily activity [<a href="#rid64">64</a>]. The catecholamine levels were lower in patients with FM than in controls. Patients with FM had significantly lower adrenaline levels during the night and the second day and had significantly lower dopamine levels during the first day, the night, and the second day. Overall, heart rate was significantly higher in patients than in controls.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Nocturnal heart rate variability (HRV) indices indicative of sympathetic predominance were significantly different in women with FM when compared with healthy individuals [<a href="#rid65">65</a>]. In patients with FM, these HRV parameters correlated with several symptoms including pain severity. Opposite associations were seen in controls. They concluded that nocturnal HRV analyses are potential FM biomarkers. Patients with FM often demonstrate a hypertonic stress response, including increased blood pressure, when exposed to a painful stimulus [<a href="#rid66">66</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Alterations in skin conductance, an indirect measure of sweating, were found in patients with FM compared with controls, and skin conductance varied less with stress and pain in FM [<a href="#rid67">67</a>]. The association of tonic sweating and ANS abnormalities in FM patients may be important in driving central sensitization [<a href="#rid68">68</a>].</p><p></p><p class="headingAnchor" id="H12284305"><span class="h1">PERIPHERAL PAIN MECHANISMS</span><span class="headingEndMark"> — </span>Although fibromyalgia (FM) is considered to be a nociplastic pain disorder, peripheral pain mechanisms are often involved. The three traditional pain categories (nociceptive, neuropathic, and nociplastic) overlap. In a patient with FM, both neuropathic and nociceptive pain must be considered [<a href="#rid69">69</a>]. (See  <a class="medical medical_review" href="/z/d/html/118590.html" rel="external">"Overview of chronic widespread (centralized) pain in the rheumatic diseases"</a>.)</p><p class="headingAnchor" id="H4155309866"><span class="h2">Small fiber neuropathy</span><span class="headingEndMark"> — </span>Several studies have suggested that FM is often associated with a small fiber neuropathy (SFN) [<a href="#rid70">70-73</a>]. SFN may be defined by a skin biopsy demonstrating reduced intraepidermal nerve fiber (IENF) density or electrochemical skin conductance (ESC) [<a href="#rid4">4</a>]. Clinically, FM may present with hyperesthesia in a stocking distribution, and there may be evidence of both a diffuse and length-dependent neuropathic process [<a href="#rid73">73</a>].</p><p>A systematic review of 222 patients with FM reported an estimated prevalence of 30 to 76 percent of SFN in FM, with a moderately high level of heterogeneity [<a href="#rid74">74</a>]. The authors concluded that 49 percent of patients with FM have "structural abnormalities of the small nerve fibers." One-hundred and fifty-five patients with FM with neuropathic symptoms underwent skin biopsies for SFN and nerve conduction studies [<a href="#rid75">75</a>]. Sixty percent were skin biopsy negative, 28 percent demonstrated distal extremity-reduced IENF density, and 12 percent had proximal extremity-reduced IENF density. Sural and medial plantar nerve conduction slowing correlated with reduced IENF density, as did markers of metabolic syndrome. However, pain quality and intensity did not distinguish patient subgroups. </p><p>However, there is a lack of consensus whether the association of reduced IENF with FM has any pathophysiologic significance [<a href="#rid76">76</a>]. For example, reduced IENF density has been found in conditions not typically associated with pain, such as amyotrophic lateral sclerosis [<a href="#rid77">77</a>]. SFN has been commonly noted in patients with complex, chronic pelvic pain [<a href="#rid78">78</a>], and there has been no correlation of reduced IENF density with neuropathic pain symptoms [<a href="#rid79">79</a>].</p><p>Central sensitization may be the driving force of SFN in FM [<a href="#rid4">4</a>]. Clinically, SFN presents with a very different pain profile than FM. The finding of SFN in the lower extremities would not account for the chronic widespread pain involving the neck, shoulders, chest wall, and trunk or the chronic fatigue, mood, and sleep disturbances characteristic of FM. Brain imaging in patients with SFN demonstrates structural and functional changes characteristic of central sensitization [<a href="#rid80">80,81</a>]. In a proof-of-concept animal study, increasing endogenous glutamate in the insula caused pain behavior and decrease in IENF density [<a href="#rid82">82</a>]. The reduction of IENF density may be very localized and distal or more generalized, and those FM patients with a generalized reduction of skin innervation had greater symptoms [<a href="#rid83">83</a>].</p><p class="headingAnchor" id="H1510104377"><span class="h2">Muscles and tendons</span><span class="headingEndMark"> — </span>Although there has been no evidence for structural muscle abnormalities in FM [<a href="#rid6">6,7</a>], one study reported lower concentrations of adenosine triphosphate (ATP) and phosphocreatinine (PCr) in quadriceps muscle in the patients with FM compared with controls [<a href="#rid84">84</a>]. The quadriceps muscle fat content was significantly greater in the patients with FM, who also exhibited lower physical capacity in the hands and legs, which correlated with the reduced concentrations of ATP and PCr. These findings were consistent with changes that could result from a combination of inactivity related to pain and muscle mitochondrial dysfunction.</p><p>Another report found that patients with FM exhibited greater variability in muscle fiber size and altered fiber size distribution compared with controls [<a href="#rid85">85</a>].</p><p>Myofascial trigger points have been considered to be a discrete source of pain in FM, although there has been controversy regarding their nature and pathology [<a href="#rid86">86</a>].</p><p class="headingAnchor" id="H2395155195"><span class="h1">IMMUNE ABNORMALITIES</span><span class="headingEndMark"> — </span>Fibromyalgia (FM) is not considered to be a classic systemic immune disorder [<a href="#rid1">1</a>]. A 2011 systematic review and meta-analysis concluded that the role of cytokines in FM is unclear [<a href="#rid87">87</a>]. A systematic analysis found significant differences in peripheral blood cytokine profiles in patients with FM compared with healthy controls, but there was no distinct pro- or antiinflammatory pattern [<a href="#rid88">88</a>]. However, the immune system interacts with both peripheral and central pain mechanisms resulting in a neuroinflammatory loop with upregulated pain peripherally and centrally [<a href="#rid89">89</a>].</p><p>This suggests that immune/inflammatory pathways sensitize peripheral and central pain pathways, creating “bottom-up” nociplastic pain.</p><p>In an animal model of FM, immunoglobulin (IgG) from FM patients injected into mice caused increased pain sensitivity in the mice and altered pain nerve fiber density [<a href="#rid90">90</a>]. Subsequently, a subset of FM patients had elevated levels of anti-SGC antibodies that correlated with symptom severity [<a href="#rid91">91</a>]. Such studies suggest that the immune system may activate glial and other brain cells, driving the chronic pain process.</p><p class="headingAnchor" id="H11"><span class="h1">SUMMARY</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Genetics</strong> – Familial, genome-wide association, and epigenetic studies imply a genetic role in fibromyalgia (FM), possibly through alteration of the serotonin and opioid pathways, but no specific candidate gene has been identified. (See <a class="local">'Genetic predisposition and candidate genes'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Central sensitization</strong> – There is conclusive evidence that alterations in central nervous system (CNS) pain processing are responsible for many of the features of FM. Brain imaging has provided the strongest evidence for this central sensitization, including an exaggerated pain response to experimental pain stimulus, altered structural and neurotransmitter function, and changes in resting-state functional connectivity. Studies suggest that an FM neurologic signature may be useful diagnostically and in future therapeutic trials. (See <a class="local">'Introduction'</a> above and <a class="local">'Terminology and pain classification'</a> above and <a class="local">'Central nervous system altered pain processing'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Nervous system hyperirritability</strong> – Fibromyalgia is associated with hyperirritability of the CNS, peripheral nervous system, and autonomic nervous system (ANS).</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Central nervous system</strong> – Sleep, mood, cognitive disturbances, stress, genetics, and environmental factors each contribute to the CNS hyperirritability. (See <a class="local">'Sleep/mood/cognitive abnormalities'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Peripheral nervous system</strong> – Genetic and environmental factors likely interact to promote a state of chronic central and peripheral nervous system hyperirritability. (See <a class="local">'Genetic predisposition and candidate genes'</a> above.)</p><p></p><p class="bulletIndent2">Other peripheral factors that may augment central pain processing include peripheral nerves and muscle. Small fiber neuropathy (SFN), defined by skin biopsy demonstrating reduced intraepidermal nerve fiber (IENF) density, has been noted commonly in FM, although its causal role is controversial. (See <a class="local">'Peripheral pain mechanisms'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Autonomic nervous system</strong> – Patients with fibromyalgia may also have dysfunction of the ANS, leading to a hyperactive stress response. (See <a class="local">'Stress/autonomic nervous system dysfunction'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Role of peripheral nociceptive mechanisms</strong> – Peripheral nociceptive mechanisms are not typically thought to play an important role in FM pathogenesis, particularly in patients with no concurrent immune or inflammatory disorder. However, especially in patients with systemic, inflammatory disease, peripheral nociceptive mechanisms are important and interact with immune/inflammatory pathways. (See <a class="local">'Peripheral pain mechanisms'</a> above.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Sluka KA, Clauw DJ. Neurobiology of fibromyalgia and chronic widespread pain. Neuroscience 2016; 338:114.</a></li><li><a class="nounderline abstract_t">López-Solà M, Woo CW, Pujol J, et al. Towards a neurophysiological signature for fibromyalgia. Pain 2017; 158:34.</a></li><li><a class="nounderline abstract_t">Nijs J, George SZ, Clauw DJ, et al. Central sensitization in chronic pain conditions: Latest discoveries and their potential for precision medicine. Lancet Rheumatol 2021; 3:e383.</a></li><li><a class="nounderline abstract_t">Dumolard A, Lefaucheur JP, Hodaj E, et al. Central Sensitization and Small-fiber Neuropathy Are Associated in Patients With Fibromyalgia. Clin J Pain 2023; 39:8.</a></li><li><a class="nounderline abstract_t">Staud R. Abnormal pain modulation in patients with spatially distributed chronic pain: fibromyalgia. Rheum Dis Clin North Am 2009; 35:263.</a></li><li><a class="nounderline abstract_t">Häkkinen A, Häkkinen K, Hannonen P, Alen M. Force production capacity and acute neuromuscular responses to fatiguing loading in women with fibromyalgia are not different from those of healthy women. J Rheumatol 2000; 27:1277.</a></li><li><a class="nounderline abstract_t">Lund E, Kendall SA, Janerot-Sjøberg B, Bengtsson A. Muscle metabolism in fibromyalgia studied by P-31 magnetic resonance spectroscopy during aerobic and anaerobic exercise. Scand J Rheumatol 2003; 32:138.</a></li><li><a class="nounderline abstract_t">Buskila D, Sarzi-Puttini P. Biology and therapy of fibromyalgia. Genetic aspects of fibromyalgia syndrome. Arthritis Res Ther 2006; 8:218.</a></li><li><a class="nounderline abstract_t">Arnold LM, Hudson JI, Hess EV, et al. Family study of fibromyalgia. Arthritis Rheum 2004; 50:944.</a></li><li><a class="nounderline abstract_t">Limer KL, Nicholl BI, Thomson W, McBeth J. Exploring the genetic susceptibility of chronic widespread pain: the tender points in genetic association studies. Rheumatology (Oxford) 2008; 47:572.</a></li><li><a class="nounderline abstract_t">Smith SB, Maixner DW, Fillingim RB, et al. Large candidate gene association study reveals genetic risk factors and therapeutic targets for fibromyalgia. Arthritis Rheum 2012; 64:584.</a></li><li><a class="nounderline abstract_t">Arnold LM, Fan J, Russell IJ, et al. The fibromyalgia family study: A genome-wide linkage scan study. Arthritis Rheum 2013; 65:1122.</a></li><li><a class="nounderline abstract_t">Dutta D, Brummett CM, Moser SE, et al. Heritability of the Fibromyalgia Phenotype Varies by Age. Arthritis Rheumatol 2020; 72:815.</a></li><li><a class="nounderline abstract_t">Kendler KS, Rosmalen JGM, Ohlsson H, et al. A distinctive profile of family genetic risk scores in a Swedish national sample of cases of fibromyalgia, irritable bowel syndrome, and chronic fatigue syndrome compared to rheumatoid arthritis and major depression. Psychol Med 2023; 53:3879.</a></li><li><a class="nounderline abstract_t">Jones KD, Gelbart T, Whisenant TC, et al. Genome-wide expression profiling in the peripheral blood of patients with fibromyalgia. Clin Exp Rheumatol 2016; 34:S89.</a></li><li><a class="nounderline abstract_t">Rahman MS, Winsvold BS, Chavez Chavez SO, et al. Genome-wide association study identifies RNF123 locus as associated with chronic widespread musculoskeletal pain. Ann Rheum Dis 2021; 80:1227.</a></li><li><a class="nounderline abstract_t">Ciampi de Andrade D, Maschietto M, Galhardoni R, et al. Epigenetics insights into chronic pain: DNA hypomethylation in fibromyalgia-a controlled pilot-study. Pain 2017; 158:1473.</a></li><li><a class="nounderline abstract_t">Polli A, Ghosh M, Bakusic J, et al. DNA Methylation and Brain-Derived Neurotrophic Factor Expression Account for Symptoms and Widespread Hyperalgesia in Patients With Chronic Fatigue Syndrome and Comorbid Fibromyalgia. Arthritis Rheumatol 2020; 72:1936.</a></li><li><a class="nounderline abstract_t">Estévez-López F, Guerrero-González JM, Salazar-Tortosa D, et al. Interplay between genetics and lifestyle on pain susceptibility in women with fibromyalgia: the al-Ándalus project. Rheumatology (Oxford) 2022; 61:3180.</a></li><li><a class="nounderline abstract_t">Tour J, Löfgren M, Mannerkorpi K, et al. Gene-to-gene interactions regulate endogenous pain modulation in fibromyalgia patients and healthy controls-antagonistic effects between opioid and serotonin-related genes. Pain 2017; 158:1194.</a></li><li><a class="nounderline abstract_t">Ellerbrock I, Sandström A, Tour J, et al. Polymorphisms of the μ-opioid receptor gene influence cerebral pain processing in fibromyalgia. Eur J Pain 2021; 25:398.</a></li><li><a class="nounderline abstract_t">O'Brien AT, Deitos A, Triñanes Pego Y, et al. Defective Endogenous Pain Modulation in Fibromyalgia: A Meta-Analysis of Temporal Summation and Conditioned Pain Modulation Paradigms. J Pain 2018; 19:819.</a></li><li><a class="nounderline abstract_t">Jensen KB, Kosek E, Petzke F, et al. Evidence of dysfunctional pain inhibition in Fibromyalgia reflected in rACC during provoked pain. Pain 2009; 144:95.</a></li><li><a class="nounderline abstract_t">Salemi S, Aeschlimann A, Wollina U, et al. Up-regulation of delta-opioid receptors and kappa-opioid receptors in the skin of fibromyalgia patients. Arthritis Rheum 2007; 56:2464.</a></li><li><a class="nounderline abstract_t">Harris RE, Clauw DJ, Scott DJ, et al. Decreased central mu-opioid receptor availability in fibromyalgia. J Neurosci 2007; 27:10000.</a></li><li><a class="nounderline abstract_t">Haas L, Portela LV, Böhmer AE, et al. Increased plasma levels of brain derived neurotrophic factor (BDNF) in patients with fibromyalgia. Neurochem Res 2010; 35:830.</a></li><li><a class="nounderline abstract_t">Hubbard CS, Lazaridou A, Cahalan CM, et al. Aberrant Salience? Brain Hyperactivation in Response to Pain Onset and Offset in Fibromyalgia. Arthritis Rheumatol 2020; 72:1203.</a></li><li><a class="nounderline abstract_t">Staud R, Godfrey MM, Robinson ME. Fibromyalgia Patients Are Not Only Hypersensitive to Painful Stimuli But Also to Acoustic Stimuli. J Pain 2021; 22:914.</a></li><li><a class="nounderline abstract_t">Gracely RH, Petzke F, Wolf JM, Clauw DJ. Functional magnetic resonance imaging evidence of augmented pain processing in fibromyalgia. Arthritis Rheum 2002; 46:1333.</a></li><li><a class="nounderline abstract_t">Napadow V, Harris RE. What has functional connectivity and chemical neuroimaging in fibromyalgia taught us about the mechanisms and management of 'centralized' pain? Arthritis Res Ther 2014; 16:425.</a></li><li><a class="nounderline abstract_t">Loggia ML, Berna C, Kim J, et al. Disrupted brain circuitry for pain-related reward/punishment in fibromyalgia. Arthritis Rheumatol 2014; 66:203.</a></li><li><a class="nounderline abstract_t">Kamping S, Bomba IC, Kanske P, et al. Deficient modulation of pain by a positive emotional context in fibromyalgia patients. Pain 2013; 154:1846.</a></li><li><a class="nounderline abstract_t">Lee J, Protsenko E, Lazaridou A, et al. Encoding of Self-Referential Pain Catastrophizing in the Posterior Cingulate Cortex in Fibromyalgia. Arthritis Rheumatol 2018; 70:1308.</a></li><li><a class="nounderline abstract_t">Müller M, Wüthrich F, Federspiel A, et al. Altered central pain processing in fibromyalgia-A multimodal neuroimaging case-control study using arterial spin labelling. PLoS One 2021; 16:e0235879.</a></li><li><a class="nounderline abstract_t">Kuchinad A, Schweinhardt P, Seminowicz DA, et al. Accelerated brain gray matter loss in fibromyalgia patients: premature aging of the brain? J Neurosci 2007; 27:4004.</a></li><li><a class="nounderline abstract_t">Jensen KB, Srinivasan P, Spaeth R, et al. Overlapping structural and functional brain changes in patients with long-term exposure to fibromyalgia pain. Arthritis Rheum 2013; 65:3293.</a></li><li><a class="nounderline abstract_t">Kim DJ, Lim M, Kim JS, et al. Altered white matter integrity in the corpus callosum in fibromyalgia patients identified by tract-based spatial statistical analysis. Arthritis Rheumatol 2014; 66:3190.</a></li><li><a class="nounderline abstract_t">Cagnie B, Coppieters I, Denecker S, et al. Central sensitization in fibromyalgia? A systematic review on structural and functional brain MRI. Semin Arthritis Rheum 2014; 44:68.</a></li><li><a class="nounderline abstract_t">Pomares FB, Funck T, Feier NA, et al. Histological Underpinnings of Grey Matter Changes in Fibromyalgia Investigated Using Multimodal Brain Imaging. J Neurosci 2017; 37:1090.</a></li><li><a class="nounderline abstract_t">Harris RE, Sundgren PC, Craig AD, et al. Elevated insular glutamate in fibromyalgia is associated with experimental pain. Arthritis Rheum 2009; 60:3146.</a></li><li><a class="nounderline abstract_t">Mhalla A, de Andrade DC, Baudic S, et al. Alteration of cortical excitability in patients with fibromyalgia. Pain 2010; 149:495.</a></li><li><a class="nounderline abstract_t">Valdés M, Collado A, Bargalló N, et al. Increased glutamate/glutamine compounds in the brains of patients with fibromyalgia: a magnetic resonance spectroscopy study. Arthritis Rheum 2010; 62:1829.</a></li><li><a class="nounderline abstract_t">Foerster BR, Petrou M, Edden RA, et al. Reduced insular γ-aminobutyric acid in fibromyalgia. Arthritis Rheum 2012; 64:579.</a></li><li><a class="nounderline abstract_t">Truini A, Tinelli E, Gerardi MC, et al. Abnormal resting state functional connectivity of the periaqueductal grey in patients with fibromyalgia. Clin Exp Rheumatol 2016; 34:S129.</a></li><li><a class="nounderline abstract_t">Fallon N, Chiu Y, Nurmikko T, Stancak A. Functional Connectivity with the Default Mode Network Is Altered in Fibromyalgia Patients. PLoS One 2016; 11:e0159198.</a></li><li><a class="nounderline abstract_t">Martucci KT, Weber KA 2nd, Mackey SC. Altered Cervical Spinal Cord Resting-State Activity in Fibromyalgia. Arthritis Rheumatol 2019; 71:441.</a></li><li><a class="nounderline abstract_t">Kaplan CM, Schrepf A, Vatansever D, et al. Functional and neurochemical disruptions of brain hub topology in chronic pain. Pain 2019; 160:973.</a></li><li><a class="nounderline abstract_t">Hsiao FJ, Chen WT, Ko YC, et al. Neuromagnetic Amygdala Response to Pain-Related Fear as a Brain Signature of Fibromyalgia. Pain Ther 2020; 9:765.</a></li><li><a class="nounderline abstract_t">Nelson T, Zhang LX, Guo H, et al. Brainstem Abnormalities in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Scoping Review and Evaluation of Magnetic Resonance Imaging Findings. Front Neurol 2021; 12:769511.</a></li><li><a class="nounderline abstract_t">Moldofsky H. The significance of dysfunctions of the sleeping/waking brain to the pathogenesis and treatment of fibromyalgia syndrome. Rheum Dis Clin North Am 2009; 35:275.</a></li><li><a class="nounderline abstract_t">Roizenblatt S, Neto NS, Tufik S. Sleep disorders and fibromyalgia. Curr Pain Headache Rep 2011; 15:347.</a></li><li><a class="nounderline abstract_t">Roehrs T, Diederichs C, Gillis M, et al. Nocturnal sleep, daytime sleepiness and fatigue in fibromyalgia patients compared to rheumatoid arthritis patients and healthy controls: a preliminary study. Sleep Med 2013; 14:109.</a></li><li><a class="nounderline abstract_t">Mork PJ, Nilsen TI. Sleep problems and risk of fibromyalgia: longitudinal data on an adult female population in Norway. Arthritis Rheum 2012; 64:281.</a></li><li><a class="nounderline abstract_t">McBeth J, Lacey RJ, Wilkie R. Predictors of new-onset widespread pain in older adults: results from a population-based prospective cohort study in the UK. Arthritis Rheumatol 2014; 66:757.</a></li><li><a class="nounderline abstract_t">Yeung WK, Morgan K, Mckenna F. Comparison of sleep structure and psychometric profiles in patients with fibromyalgia, osteoarthritis and healthy controls. J Sleep Res 2018; 27:290.</a></li><li><a class="nounderline abstract_t">Fang SC, Wu YL, Chen SC, et al. Subjective sleep quality as a mediator in the relationship between pain severity and sustained attention performance in patients with fibromyalgia. J Sleep Res 2019; 28:e12843.</a></li><li><a class="nounderline abstract_t">Rizzi M, Radovanovic D, Santus P, et al. Influence of autonomic nervous system dysfunction in the genesis of sleep disorders in fibromyalgia patients. Clin Exp Rheumatol 2017; 35 Suppl 105:74.</a></li><li><a class="nounderline abstract_t">Adler GK, Kinsley BT, Hurwitz S, et al. Reduced hypothalamic-pituitary and sympathoadrenal responses to hypoglycemia in women with fibromyalgia syndrome. Am J Med 1999; 106:534.</a></li><li><a class="nounderline abstract_t">McLean SA, Williams DA, Stein PK, et al. Cerebrospinal fluid corticotropin-releasing factor concentration is associated with pain but not fatigue symptoms in patients with fibromyalgia. Neuropsychopharmacology 2006; 31:2776.</a></li><li><a class="nounderline abstract_t">McLean SA, Williams DA, Harris RE, et al. Momentary relationship between cortisol secretion and symptoms in patients with fibromyalgia. Arthritis Rheum 2005; 52:3660.</a></li><li><a class="nounderline abstract_t">McBeth J, Silman AJ, Gupta A, et al. Moderation of psychosocial risk factors through dysfunction of the hypothalamic-pituitary-adrenal stress axis in the onset of chronic widespread musculoskeletal pain: findings of a population-based prospective cohort study. Arthritis Rheum 2007; 56:360.</a></li><li><a class="nounderline abstract_t">Barceló-Martinez E, Gelves-Ospina M, Navarro Lechuga E, et al. Serum cortisol levels and neuropsychological impairments in patients diagnosed with Fibromyalgia. Actas Esp Psiquiatr 2018; 46:1.</a></li><li><a class="nounderline abstract_t">Beiner E, Lucas V, Reichert J, et al. Stress biomarkers in individuals with fibromyalgia syndrome: a systematic review with meta-analysis. Pain 2023; 164:1416.</a></li><li><a class="nounderline abstract_t">Riva R, Mork PJ, Westgaard RH, et al. Catecholamines and heart rate in female fibromyalgia patients. J Psychosom Res 2012; 72:51.</a></li><li><a class="nounderline abstract_t">Lerma C, Martinez A, Ruiz N, et al. Nocturnal heart rate variability parameters as potential fibromyalgia biomarker: correlation with symptoms severity. Arthritis Res Ther 2011; 13:R185.</a></li><li><a class="nounderline abstract_t">Reyes del Paso GA, Duschek S. Responses to a comment on "autonomic cardiovascular control and responses to experimental pain stimulation in fibromyalgia syndrome". J Psychosom Res 2012; 72:87.</a></li><li><a class="nounderline abstract_t">Reyes Del Paso GA, de la Coba P. Reduced activity, reactivity and functionality of the sympathetic nervous system in fibromyalgia: An electrodermal study. PLoS One 2020; 15:e0241154.</a></li><li><a class="nounderline abstract_t">Garcia-Hernandez A, de la Coba P, Reyes Del Paso GA. Central sensitisation pain and autonomic deficiencies in fibromyalgia. Clin Exp Rheumatol 2022; 40:1202.</a></li><li><a class="nounderline abstract_t">Murphy AE, Minhas D, Clauw DJ, Lee YC. Identifying and Managing Nociplastic Pain in Individuals With Rheumatic Diseases: A Narrative Review. Arthritis Care Res (Hoboken) 2023; 75:2215.</a></li><li><a class="nounderline abstract_t">Üçeyler N, Zeller D, Kahn AK, et al. Small fibre pathology in patients with fibromyalgia syndrome. Brain 2013; 136:1857.</a></li><li><a class="nounderline abstract_t">Oaklander AL, Herzog ZD, Downs HM, Klein MM. Objective evidence that small-fiber polyneuropathy underlies some illnesses currently labeled as fibromyalgia. Pain 2013; 154:2310.</a></li><li><a class="nounderline abstract_t">Giannoccaro MP, Donadio V, Incensi A, et al. Small nerve fiber involvement in patients referred for fibromyalgia. Muscle Nerve 2014; 49:757.</a></li><li><a class="nounderline abstract_t">Caro XJ, Winter EF. Evidence of abnormal epidermal nerve fiber density in fibromyalgia: clinical and immunologic implications. Arthritis Rheumatol 2014; 66:1945.</a></li><li><a class="nounderline abstract_t">Grayston R, Czanner G, Elhadd K, et al. A systematic review and meta-analysis of the prevalence of small fiber pathology in fibromyalgia: Implications for a new paradigm in fibromyalgia etiopathogenesis. Semin Arthritis Rheum 2019; 48:933.</a></li><li><a class="nounderline abstract_t">Lawson VH, Grewal J, Hackshaw KV, et al. Fibromyalgia syndrome and small fiber, early or mild sensory polyneuropathy. Muscle Nerve 2018; 58:625.</a></li><li><a class="nounderline abstract_t">Clauw DJ. What is the meaning of "small fiber neuropathy" in fibromyalgia? Pain 2015; 156:2115.</a></li><li><a class="nounderline abstract_t">Dalla Bella E, Lombardi R, Porretta-Serapiglia C, et al. Amyotrophic lateral sclerosis causes small fiber pathology. Eur J Neurol 2016; 23:416.</a></li><li><a class="nounderline abstract_t">Chen A, De E, Argoff C. Small Fiber Polyneuropathy Is Prevalent in Patients Experiencing Complex Chronic Pelvic Pain. Pain Med 2019; 20:521.</a></li><li><a class="nounderline abstract_t">Gandhi RA, Selvarajah D. Understanding and treating painful diabetic neuropathy: time for a paradigm shift. Diabet Med 2015; 32:771.</a></li><li><a class="nounderline abstract_t">Hsieh PC, Tseng MT, Chao CC, et al. Imaging signatures of altered brain responses in small-fiber neuropathy: reduced functional connectivity of the limbic system after peripheral nerve degeneration. Pain 2015; 156:904.</a></li><li><a class="nounderline abstract_t">Chao CC, Tseng MT, Lin YH, et al. Brain imaging signature of neuropathic pain phenotypes in small-fiber neuropathy: altered thalamic connectome and its associations with skin nerve degeneration. Pain 2021; 162:1387.</a></li><li><a class="nounderline abstract_t">Harte SE, Clauw DJ, Hayes JM, et al. Reduced intraepidermal nerve fiber density after a sustained increase in insular glutamate: a proof-of-concept study examining the pathogenesis of small fiber pathology in fibromyalgia. Pain Rep 2017; 2:e590.</a></li><li><a class="nounderline abstract_t">Evdokimov D, Frank J, Klitsch A, et al. Reduction of skin innervation is associated with a severe fibromyalgia phenotype. Ann Neurol 2019; 86:504.</a></li><li><a class="nounderline abstract_t">Gerdle B, Forsgren MF, Bengtsson A, et al. Decreased muscle concentrations of ATP and PCR in the quadriceps muscle of fibromyalgia patients--a 31P-MRS study. Eur J Pain 2013; 17:1205.</a></li><li><a class="nounderline abstract_t">Srikuea R, Symons TB, Long DE, et al. Association of fibromyalgia with altered skeletal muscle characteristics which may contribute to postexertional fatigue in postmenopausal women. Arthritis Rheum 2013; 65:519.</a></li><li><a class="nounderline abstract_t">Fernández-de-Las-Peñas C, Nijs J, Cagnie B, et al. Myofascial Pain Syndrome: A Nociceptive Condition Comorbid with Neuropathic or Nociplastic Pain. Life (Basel) 2023; 13.</a></li><li><a class="nounderline abstract_t">Uçeyler N, Häuser W, Sommer C. Systematic review with meta-analysis: cytokines in fibromyalgia syndrome. BMC Musculoskelet Disord 2011; 12:245.</a></li><li><a class="nounderline abstract_t">O'Mahony LF, Srivastava A, Mehta P, Ciurtin C. Is fibromyalgia associated with a unique cytokine profile? A systematic review and meta-analysis. Rheumatology (Oxford) 2021; 60:2602.</a></li><li><a class="nounderline abstract_t">Sunzini F, Schrepf A, Clauw DJ, Basu N. The Biology of Pain: Through the Rheumatology Lens. Arthritis Rheumatol 2023; 75:650.</a></li><li><a class="nounderline abstract_t">Goebel A, Krock E, Gentry C, et al. Passive transfer of fibromyalgia symptoms from patients to mice. J Clin Invest 2021; 131.</a></li><li><a class="nounderline abstract_t">Krock E, Morado-Urbina CE, Menezes J, et al. Fibromyalgia patients with elevated levels of anti-satellite glia cell immunoglobulin G antibodies present with more severe symptoms. Pain 2023; 164:1828.</a></li></ol></div><div id="topicVersionRevision">Topic 5626 Version 22.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27291641" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Neurobiology of fibromyalgia and chronic widespread pain.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27583567" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Towards a neurophysiological signature for fibromyalgia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Central sensitization in chronic pain conditions: Latest discoveries and their potential for precision medicine</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36524768" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Central Sensitization and Small-fiber Neuropathy Are Associated in Patients With Fibromyalgia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19647141" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Abnormal pain modulation in patients with spatially distributed chronic pain: fibromyalgia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10813301" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Force production capacity and acute neuromuscular responses to fatiguing loading in women with fibromyalgia are not different from those of healthy women.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12892249" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Muscle metabolism in fibromyalgia studied by P-31 magnetic resonance spectroscopy during aerobic and anaerobic exercise.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16887010" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Biology and therapy of fibromyalgia. Genetic aspects of fibromyalgia syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15022338" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Family study of fibromyalgia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18321946" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Exploring the genetic susceptibility of chronic widespread pain: the tender points in genetic association studies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21905019" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Large candidate gene association study reveals genetic risk factors and therapeutic targets for fibromyalgia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23280346" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : The fibromyalgia family study: A genome-wide linkage scan study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31736264" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Heritability of the Fibromyalgia Phenotype Varies by Age.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35354508" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : A distinctive profile of family genetic risk scores in a Swedish national sample of cases of fibromyalgia, irritable bowel syndrome, and chronic fatigue syndrome compared to rheumatoid arthritis and major depression.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27157394" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Genome-wide expression profiling in the peripheral blood of patients with fibromyalgia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33926923" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Genome-wide association study identifies RNF123 locus as associated with chronic widespread musculoskeletal pain.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28621701" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Epigenetics insights into chronic pain: DNA hypomethylation in fibromyalgia-a controlled pilot-study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32562379" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : DNA Methylation and Brain-Derived Neurotrophic Factor Expression Account for Symptoms and Widespread Hyperalgesia in Patients With Chronic Fatigue Syndrome and Comorbid Fibromyalgia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34875034" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Interplay between genetics and lifestyle on pain susceptibility in women with fibromyalgia: the al-Ándalus project.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28282362" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Gene-to-gene interactions regulate endogenous pain modulation in fibromyalgia patients and healthy controls-antagonistic effects between opioid and serotonin-related genes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33064887" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Polymorphisms of theμ-opioid receptor gene influence cerebral pain processing in fibromyalgia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29454976" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Defective Endogenous Pain Modulation in Fibromyalgia: A Meta-Analysis of Temporal Summation and Conditioned Pain Modulation Paradigms.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19410366" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Evidence of dysfunctional pain inhibition in Fibromyalgia reflected in rACC during provoked pain.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17599756" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Up-regulation of delta-opioid receptors and kappa-opioid receptors in the skin of fibromyalgia patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17855614" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Decreased central mu-opioid receptor availability in fibromyalgia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20119637" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Increased plasma levels of brain derived neurotrophic factor (BDNF) in patients with fibromyalgia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32017421" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Aberrant Salience? Brain Hyperactivation in Response to Pain Onset and Offset in Fibromyalgia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33636370" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Fibromyalgia Patients Are Not Only Hypersensitive to Painful Stimuli But Also to Acoustic Stimuli.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12115241" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Functional magnetic resonance imaging evidence of augmented pain processing in fibromyalgia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25606591" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : What has functional connectivity and chemical neuroimaging in fibromyalgia taught us about the mechanisms and management of 'centralized' pain?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24449585" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Disrupted brain circuitry for pain-related reward/punishment in fibromyalgia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23752177" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Deficient modulation of pain by a positive emotional context in fibromyalgia patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29579370" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Encoding of Self-Referential Pain Catastrophizing in the Posterior Cingulate Cortex in Fibromyalgia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33529254" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Altered central pain processing in fibromyalgia-A multimodal neuroimaging case-control study using arterial spin labelling.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17428976" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Accelerated brain gray matter loss in fibromyalgia patients: premature aging of the brain?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23982850" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Overlapping structural and functional brain changes in patients with long-term exposure to fibromyalgia pain.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25225152" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Altered white matter integrity in the corpus callosum in fibromyalgia patients identified by tract-based spatial statistical analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24508406" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Central sensitization in fibromyalgia? A systematic review on structural and functional brain MRI.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27986927" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Histological Underpinnings of Grey Matter Changes in Fibromyalgia Investigated Using Multimodal Brain Imaging.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19790053" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Elevated insular glutamate in fibromyalgia is associated with experimental pain.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20356675" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Alteration of cortical excitability in patients with fibromyalgia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20191578" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Increased glutamate/glutamine compounds in the brains of patients with fibromyalgia: a magnetic resonance spectroscopy study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21913179" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Reduced insularγ-aminobutyric acid in fibromyalgia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27157397" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Abnormal resting state functional connectivity of the periaqueductal grey in patients with fibromyalgia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27442504" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Functional Connectivity with the Default Mode Network Is Altered in Fibromyalgia Patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30281205" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Altered Cervical Spinal Cord Resting-State Activity in Fibromyalgia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30763287" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Functional and neurochemical disruptions of brain hub topology in chronic pain.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33090368" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Neuromagnetic Amygdala Response to Pain-Related Fear as a Brain Signature of Fibromyalgia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34975729" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Brainstem Abnormalities in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Scoping Review and Evaluation of Magnetic Resonance Imaging Findings.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19647142" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : The significance of dysfunctions of the sleeping/waking brain to the pathogenesis and treatment of fibromyalgia syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21594765" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Sleep disorders and fibromyalgia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23149217" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Nocturnal sleep, daytime sleepiness and fatigue in fibromyalgia patients compared to rheumatoid arthritis patients and healthy controls: a preliminary study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22081440" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Sleep problems and risk of fibromyalgia: longitudinal data on an adult female population in Norway.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24574238" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Predictors of new-onset widespread pain in older adults: results from a population-based prospective cohort study in the UK.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28799194" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Comparison of sleep structure and psychometric profiles in patients with fibromyalgia, osteoarthritis and healthy controls.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30920084" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Subjective sleep quality as a mediator in the relationship between pain severity and sustained attention performance in patients with fibromyalgia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28681708" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Influence of autonomic nervous system dysfunction in the genesis of sleep disorders in fibromyalgia patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10335725" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Reduced hypothalamic-pituitary and sympathoadrenal responses to hypoglycemia in women with fibromyalgia syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16936702" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Cerebrospinal fluid corticotropin-releasing factor concentration is associated with pain but not fatigue symptoms in patients with fibromyalgia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16258904" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Momentary relationship between cortisol secretion and symptoms in patients with fibromyalgia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17195240" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Moderation of psychosocial risk factors through dysfunction of the hypothalamic-pituitary-adrenal stress axis in the onset of chronic widespread musculoskeletal pain: findings of a population-based prospective cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29417976" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Serum cortisol levels and neuropsychological impairments in patients diagnosed with Fibromyalgia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36728497" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Stress biomarkers in individuals with fibromyalgia syndrome: a systematic review with meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22200523" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Catecholamines and heart rate in female fibromyalgia patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22087605" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Nocturnal heart rate variability parameters as potential fibromyalgia biomarker: correlation with symptoms severity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22200530" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Responses to a comment on "autonomic cardiovascular control and responses to experimental pain stimulation in fibromyalgia syndrome".</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33119628" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Reduced activity, reactivity and functionality of the sympathetic nervous system in fibromyalgia: An electrodermal study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35748717" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Central sensitisation pain and autonomic deficiencies in fibromyalgia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36785994" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Identifying and Managing Nociplastic Pain in Individuals With Rheumatic Diseases: A Narrative Review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23474848" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Small fibre pathology in patients with fibromyalgia syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23748113" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Objective evidence that small-fiber polyneuropathy underlies some illnesses currently labeled as fibromyalgia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24469976" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Small nerve fiber involvement in patients referred for fibromyalgia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24719395" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Evidence of abnormal epidermal nerve fiber density in fibromyalgia: clinical and immunologic implications.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30314675" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : A systematic review and meta-analysis of the prevalence of small fiber pathology in fibromyalgia: Implications for a new paradigm in fibromyalgia etiopathogenesis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29572887" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Fibromyalgia syndrome and small fiber, early or mild sensory polyneuropathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26307862" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : What is the meaning of "small fiber neuropathy" in fibromyalgia?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26806218" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Amyotrophic lateral sclerosis causes small fiber pathology.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29447372" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Small Fiber Polyneuropathy Is Prevalent in Patients Experiencing Complex Chronic Pelvic Pain.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25818649" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : Understanding and treating painful diabetic neuropathy: time for a paradigm shift.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25734991" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : Imaging signatures of altered brain responses in small-fiber neuropathy: reduced functional connectivity of the limbic system after peripheral nerve degeneration.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33239524" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : Brain imaging signature of neuropathic pain phenotypes in small-fiber neuropathy: altered thalamic connectome and its associations with skin nerve degeneration.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29392206" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : Reduced intraepidermal nerve fiber density after a sustained increase in insular glutamate: a proof-of-concept study examining the pathogenesis of small fiber pathology in fibromyalgia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31376174" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : Reduction of skin innervation is associated with a severe fibromyalgia phenotype.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23364928" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : Decreased muscle concentrations of ATP and PCR in the quadriceps muscle of fibromyalgia patients--a 31P-MRS study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23124535" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : Association of fibromyalgia with altered skeletal muscle characteristics which may contribute to postexertional fatigue in postmenopausal women.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36983849" id="rid85" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>86 : Myofascial Pain Syndrome: A Nociceptive Condition Comorbid with Neuropathic or Nociplastic Pain.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22034969" id="rid86" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>87 : Systematic review with meta-analysis: cytokines in fibromyalgia syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33576773" id="rid87" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>88 : Is fibromyalgia associated with a unique cytokine profile? A systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36599071" id="rid88" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>89 : The Biology of Pain: Through the Rheumatology Lens.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34196305" id="rid89" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>90 : Passive transfer of fibromyalgia symptoms from patients to mice.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36943275" id="rid90" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>91 : Fibromyalgia patients with elevated levels of anti-satellite glia cell immunoglobulin G antibodies present with more severe symptoms.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
